CAMT vs. RVTY, AVTR, BIO.B, NVMI, VNT, MIR, ST, TXG, TRNS, and ALNT
Should you be buying Camtek stock or one of its competitors? The main competitors of Camtek include Revvity (RVTY), Avantor (AVTR), Bio-Rad Laboratories (BIO.B), Nova (NVMI), Vontier (VNT), Mirion Technologies (MIR), Sensata Technologies (ST), 10x Genomics (TXG), Transcat (TRNS), and Allient (ALNT). These companies are all part of the "measuring and control equipment" industry.
Camtek vs.
Camtek (NASDAQ:CAMT) and Revvity (NYSE:RVTY) are both computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, community ranking, institutional ownership, analyst recommendations, risk, profitability and earnings.
Camtek pays an annual dividend of $1.33 per share and has a dividend yield of 1.8%. Revvity pays an annual dividend of $0.28 per share and has a dividend yield of 0.3%. Camtek pays out 51.0% of its earnings in the form of a dividend. Revvity pays out 11.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.
41.9% of Camtek shares are owned by institutional investors. Comparatively, 86.7% of Revvity shares are owned by institutional investors. 79.4% of Camtek shares are owned by company insiders. Comparatively, 0.7% of Revvity shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Camtek has a net margin of 27.61% compared to Revvity's net margin of 9.81%. Camtek's return on equity of 24.99% beat Revvity's return on equity.
Camtek received 528 more outperform votes than Revvity when rated by MarketBeat users. Likewise, 71.09% of users gave Camtek an outperform vote while only 62.50% of users gave Revvity an outperform vote.
Revvity has higher revenue and earnings than Camtek. Camtek is trading at a lower price-to-earnings ratio than Revvity, indicating that it is currently the more affordable of the two stocks.
In the previous week, Camtek had 1 more articles in the media than Revvity. MarketBeat recorded 6 mentions for Camtek and 5 mentions for Revvity. Camtek's average media sentiment score of 1.47 beat Revvity's score of 0.97 indicating that Camtek is being referred to more favorably in the media.
Camtek currently has a consensus price target of $90.78, suggesting a potential upside of 19.93%. Revvity has a consensus price target of $125.64, suggesting a potential upside of 30.53%. Given Revvity's higher possible upside, analysts clearly believe Revvity is more favorable than Camtek.
Camtek has a beta of 1.29, indicating that its share price is 29% more volatile than the S&P 500. Comparatively, Revvity has a beta of 0.97, indicating that its share price is 3% less volatile than the S&P 500.
Summary
Camtek beats Revvity on 13 of the 20 factors compared between the two stocks.
Get Camtek News Delivered to You Automatically
Sign up to receive the latest news and ratings for CAMT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Related Companies and Tools
This page (NASDAQ:CAMT) was last updated on 6/10/2025 by MarketBeat.com Staff